Cargando…
Initial clinical outcomes of intracoronary infusion of autologous progenitor cells in patients with acute myocardial infarction
BACKGROUND: Myocardial infarction (MI) is an irreversible cardiomyocytes injury which begins after 15–20 minutes of coronary artery occlusion. The extent of infarction is modulated by a number of factors including collateral blood supplies, medications, and ischemic preconditioning. Although angiopl...
Autores principales: | Jazi, Seyed Mohammad Hashemi, Esfahani, Mohammad Hossein Nasr, Fesharaki, Mehrafarin, Moulavi, Fariba, Gharipour, Mojgan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413085/ https://www.ncbi.nlm.nih.gov/pubmed/23205050 |
Ejemplares similares
-
Treatment of full thickness cartilage defects in human knees with Autologous Chondrocyte Transplantation*
por: Nazem, Khalilallah, et al.
Publicado: (2011) -
Soft tissue augmentation by autologous cultured fibroblasts transplantation for treatment of wrinkles and scars: a case series of 20 patients
por: Nilforoushzadeh, Mohammad Ali, et al.
Publicado: (2010) -
The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction
por: Peregud-Pogorzelska, Małgorzata, et al.
Publicado: (2020) -
Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis
por: Hristov, M, et al.
Publicado: (2006) -
Intracoronary infusion of mononuclear cells after PCI-treated myocardial infarction and arrhythmogenesis: is it safe?
por: Robbers, L. F. H. J., et al.
Publicado: (2012)